Published in Mol Imaging Biol on December 01, 2010
The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol (2011) 3.24
Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. Open Surg Oncol J (2010) 2.50
A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging (2012) 2.18
Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging (2012) 1.49
Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance. J Am Chem Soc (2013) 1.43
Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol (2012) 1.30
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI Res (2011) 1.16
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res (2015) 1.14
Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol (2011) 1.09
IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Mol Imaging Biol (2015) 1.08
Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope (2013) 1.04
In vivo imaging of human and mouse skin with a handheld dual-axis confocal fluorescence microscope. J Invest Dermatol (2010) 1.04
Fast multispectral optoacoustic tomography (MSOT) for dynamic imaging of pharmacokinetics and biodistribution in multiple organs. PLoS One (2012) 1.03
Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug Chem (2012) 0.99
Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imaging Biol (2012) 0.99
In vivo bio-imaging using chlorotoxin-based conjugates. Curr Pharm Des (2011) 0.97
Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res (2012) 0.96
A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies. EJNMMI Res (2012) 0.96
Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single- or dual-mode fluorescence and PET imaging. Nat Protoc (2013) 0.96
Seeing it through: translational validation of new medical imaging modalities. Biomed Opt Express (2012) 0.94
Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe. Nat Med (2014) 0.93
Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer. J Surg Res (2013) 0.93
Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther (2013) 0.92
Application of fluorescence in robotic general surgery: review of the literature and state of the art. World J Surg (2013) 0.92
Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo. Angiogenesis (2013) 0.89
Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging. Mol Imaging Biol (2012) 0.89
Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem (2015) 0.86
Near-infrared fluorescence imaging of mammalian cells and xenograft tumors with SNAP-tag. PLoS One (2012) 0.85
Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors. Int J Cancer (2015) 0.84
The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng (2011) 0.84
A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors. Cancer Biol Ther (2013) 0.82
Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer. Transl Androl Urol (2013) 0.81
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer. Int J Cancer (2015) 0.81
Near-infrared optical imaging for monitoring the regeneration of osteogenic tissue-engineered constructs. Biores Open Access (2013) 0.81
Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis. Oncotarget (2014) 0.81
Exogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives. Expert Opin Med Diagn (2011) 0.80
Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging. PLoS One (2012) 0.79
700-nm Zwitterionic Near-Infrared Fluorophores for Dual-Channel Image-Guided Surgery. Mol Imaging Biol (2016) 0.78
Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol (2017) 0.78
Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging. J Nanobiotechnology (2010) 0.78
Towards clinically translatable NIR fluorescence molecular guidance for colonoscopy. Biomed Opt Express (2013) 0.78
Non-invasive imaging of tumors by monitoring autotaxin activity using an enzyme-activated near-infrared fluorogenic substrate. PLoS One (2013) 0.78
Optical mesoscopy without the scatter: broadband multispectral optoacoustic mesoscopy. Biomed Opt Express (2015) 0.77
Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging. Bioconjug Chem (2010) 0.77
Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Br J Neurosurg (2015) 0.77
Stromal Targets for Fluorescent-Guided Oncologic Surgery. Front Oncol (2015) 0.77
Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models. Oncotarget (2015) 0.77
In Vivo Imaging of Retinal Oxidative Stress Using a Reactive Oxygen Species-Activated Fluorescent Probe. Invest Ophthalmol Vis Sci (2015) 0.77
Advancing Molecular-Guided Surgery through probe development and testing in a moderate cost evaluation pipeline. Proc SPIE Int Soc Opt Eng (2015) 0.76
Determining the Performance of Fluorescence Molecular Imaging Devices Using Traceable Working Standards With SI Units of Radiance. IEEE Trans Med Imaging (2015) 0.76
Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies. Laryngoscope (2016) 0.75
Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use. Mol Imaging Biol (2016) 0.75
A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer. Oncotarget (2016) 0.75
Laparoscopic Fluorescent Visualization of the Ureter With Intravenous IRDye800CW. J Minim Invasive Gynecol (2015) 0.75
Highly selective fluorescent chemosensor for Zn2+ derived from inorganic-organic hybrid magnetic core/shell Fe3O4@SiO2 nanoparticles. Nanoscale Res Lett (2012) 0.75
Biological evaluation of a novel fluorescent-imaging agent for medullary thyroid cancer in an orthotopic model. J Clin Endocrinol Metab (2017) 0.75
Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology (2008) 4.15
Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol (2006) 3.98
Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer (2005) 3.62
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt (2007) 3.04
Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol (2009) 2.61
Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg (2008) 2.43
Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. J Neurosurg (2005) 2.42
Adverse reactions due to indocyanine green. Ophthalmology (1994) 2.30
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med (2007) 2.16
Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt (2005) 1.70
Near-infrared fluorescence optical imaging and tomography. Dis Markers (2004) 1.51
Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci (2003) 1.50
Intraoperative coronary angiography using fluorescein. Ann Thorac Surg (1991) 1.48
Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg (2007) 1.47
Reference values for young normal Sprague-Dawley rats: weight gain, hematology and clinical chemistry. Hum Exp Toxicol (1996) 1.31
Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg (2008) 1.31
Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Br J Clin Pharmacol (1980) 1.28
Survey of complications of indocyanine green angiography in Japan. Am J Ophthalmol (1994) 1.07
Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci (2006) 1.00
Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg (2007) 1.00
Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs. Toxicol Appl Pharmacol (1969) 0.98
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography. Invest Ophthalmol Vis Sci (2006) 0.96
Retinal tolerance to dyes. Br J Ophthalmol (2005) 0.93
Chemical toxicity of indocyanine green damages retinal pigment epithelium. Invest Ophthalmol Vis Sci (2005) 0.90
Detecting recurrent choroidal neovascularization. Comparison of clinical examination with and without fluorescein angiography. Arch Ophthalmol (1994) 0.81
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt (2007) 3.04
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol (2009) 2.61
Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. Open Surg Oncol J (2010) 2.50
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res (2003) 2.25
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med (2007) 2.16
New horizons for imaging lymphatic function. Ann N Y Acad Sci (2008) 2.00
Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol (2007) 1.96
Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol (2007) 1.96
Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. Mol Imaging Biol (2013) 1.77
Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt (2005) 1.70
A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem (2007) 1.70
Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging (2004) 1.64
Three-dimensional fluorescence lifetime tomography. Med Phys (2005) 1.59
Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence. Transl Oncol (2010) 1.53
Near-infrared fluorescence optical imaging and tomography. Dis Markers (2004) 1.51
Fluorescence-enhanced optical imaging in large tissue volumes using a gain-modulated ICCD camera. Phys Med Biol (2003) 1.47
Functional lymphatic imaging in tumor-bearing mice. J Immunol Methods (2010) 1.45
Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging. Arch Phys Med Rehabil (2011) 1.40
Three-dimensional, Bayesian image reconstruction from sparse and noisy data sets: near-infrared fluorescence tomography. Proc Natl Acad Sci U S A (2002) 1.34
Small animal fluorescence and bioluminescence tomography: a review of approaches, algorithms and technology update. Phys Med Biol (2013) 1.34
Non-contact fluorescence optical tomography with scanning patterned illumination. Opt Express (2006) 1.34
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem (2008) 1.31
Fully adaptive FEM based fluorescence optical tomography from time-dependent measurements with area illumination and detection. Med Phys (2006) 1.31
Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express (2010) 1.31
Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent. Transl Oncol (2010) 1.26
A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy. Anal Biochem (2005) 1.25
Improved excitation light rejection enhances small-animal fluorescent optical imaging. Mol Imaging (2005) 1.25
A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. Bioconjug Chem (2007) 1.24
Near infrared fluorescent optical imaging for nodal staging. J Biomed Opt (2008) 1.21
Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF. J Nucl Med (2012) 1.20
Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci U S A (2013) 1.17
Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother (2009) 1.16
Reduction of excitation light leakage to improve near-infrared fluorescence imaging for tissue surface and deep tissue imaging. Med Phys (2010) 1.14
Radiative transport-based frequency-domain fluorescence tomography. Phys Med Biol (2008) 1.13
Mouse phenotyping with near-infrared fluorescence lymphatic imaging. Biomed Opt Express (2011) 1.13
Three-dimensional fluorescence enhanced optical tomography using referenced frequency-domain photon migration measurements at emission and excitation wavelengths. J Opt Soc Am A Opt Image Sci Vis (2002) 1.12
Imaging prostate cancer lymph node metastases with a multimodality contrast agent. Prostate (2011) 1.11
Near-infrared fluorescence imaging of lymphatics in head and neck lymphedema. Head Neck (2010) 1.08
Assessment of a fluorescence-enhanced optical imaging system using the Hotelling observer. Opt Express (2006) 1.07
Emerging lymphatic imaging technologies for mouse and man. J Clin Invest (2014) 1.06
Sensitivity and depth penetration of continuous wave versus frequency-domain photon migration near-infrared fluorescence contrast-enhanced imaging. Photochem Photobiol (2003) 1.06
Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi's sarcoma. Mol Imaging (2005) 1.05
Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine (2013) 1.04
Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model. Tissue Eng Part A (2011) 1.03
Fluorescence lifetime spectroscopy in multiply scattering media with dyes exhibiting multiexponential decay kinetics. Biophys J (2002) 1.03
A nonfluorescent, broad-range quencher dye for Förster resonance energy transfer assays. Anal Biochem (2009) 1.02
Near-infrared fluorescence contrast-enhanced imaging with intensified charge-coupled device homodyne detection: measurement precision and accuracy. J Biomed Opt (2003) 1.00
Monte Carlo simulation of time-dependent, transport-limited fluorescent boundary measurements in frequency domain. Med Phys (2007) 0.99
Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imaging Biol (2012) 0.99
Detection of single and multiple targets in tissue phantoms with fluorescence-enhanced optical imaging: feasibility study. Radiology (2005) 0.99
Quantifying molecular specificity of alphavbeta3 integrin-targeted optical contrast agents with dynamic optical imaging. J Biomed Opt (2005) 0.99
A parallel adaptive finite element simplified spherical harmonics approximation solver for frequency domain fluorescence molecular imaging. Phys Med Biol (2010) 0.98
Targeting pili in enterococcal pathogenesis. Infect Immun (2014) 0.97
Near-infrared-labeled tetracycline derivative is an effective marker of bone deposition in mice. Anal Biochem (2011) 0.96
Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification. Tissue Eng Part A (2010) 0.96
Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res (2012) 0.96
Fluorescence-enhanced optical tomography using referenced measurements of heterogeneous media. IEEE Trans Med Imaging (2003) 0.95
Seeing it through: translational validation of new medical imaging modalities. Biomed Opt Express (2012) 0.94
An abnormal lymphatic phenotype is associated with subcutaneous adipose tissue deposits in Dercum's disease. Obesity (Silver Spring) (2014) 0.93
Plane-wave fluorescence tomography with adaptive finite elements. Opt Lett (2006) 0.92
Fluorescence lifetime spectroscopy of a pH-sensitive dye encapsulated in hydrogel beads. Biotechnol Prog (2004) 0.91
Multimodal chelation platform for near-infrared fluorescence/nuclear imaging. J Med Chem (2013) 0.91
Fully adaptive finite element based tomography using tetrahedral dual-meshing for fluorescence enhanced optical imaging in tissue. Opt Express (2007) 0.91
Near-infrared fluorescence contrast-enhanced imaging with area illumination and area detection: the forward imaging problem. Appl Opt (2003) 0.90
Evaluation of anatomical structure and non-uniform distribution of imaging agent in near-infrared fluorescence-enhanced optical tomography. Opt Express (2005) 0.90
Direct visualization of changes of lymphatic function and drainage pathways in lymph node metastasis of B16F10 melanoma using near-infrared fluorescence imaging. Biomed Opt Express (2013) 0.90
Radiative transport in fluorescence-enhanced frequency domain photon migration. Med Phys (2006) 0.90
Altered lymphatic function and architecture in salt-induced hypertension assessed by near-infrared fluorescence imaging. J Biomed Opt (2012) 0.89
Near-infrared fluorescence detection permits accurate imaging of loading controls for Western blot analysis. Anal Biochem (2007) 0.89
A compact frequency-domain photon migration system for integration into commercial hybrid small animal imaging scanners for fluorescence tomography. Phys Med Biol (2012) 0.89
Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging. Mol Imaging Biol (2012) 0.89
Measurements of FRET in a glucose-sensitive affinity system with frequency-domain lifetime spectroscopy. Photochem Photobiol (2005) 0.87
Fluorescence lifetime spectroscopy for pH sensing in scattering media. Anal Chem (2003) 0.86
Non-invasive optical imaging of the lymphatic vasculature of a mouse. J Vis Exp (2013) 0.86
Improvement of fluorescence-enhanced optical tomography with improved optical filtering and accurate model-based reconstruction algorithms. J Biomed Opt (2011) 0.86
beta-Galactosidase activity assay using far-red-shifted fluorescent substrate DDAOG. Anal Biochem (2008) 0.86
Near-infrared fluorescence imaging of mammalian cells and xenograft tumors with SNAP-tag. PLoS One (2012) 0.85
The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng (2011) 0.84
Lymphatic vascular response to acute inflammation. PLoS One (2013) 0.84
Detection of lymphangiogenesis by near-infrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model. Wound Repair Regen (2013) 0.84
In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation. J Biomed Opt (2013) 0.84
Automated analysis of investigational near-infrared fluorescence lymphatic imaging in humans. Biomed Opt Express (2012) 0.84
Assessment of free dye in solutions of dual-labeled antibody conjugates for in vivo molecular imaging. Mol Imaging Biol (2011) 0.84
Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging. Biomed Opt Express (2012) 0.83
The need for performance standards in clinical translation and adoption of fluorescence molecular imaging. Med Phys (2013) 0.82
Blocking and detection chemistries affect antibody performance on reverse phase protein arrays. Proteomics (2008) 0.82
Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide. Bioorg Med Chem (2011) 0.82
Fluorescence-enhanced optical tomography of a large tissue phantom using point illumination geometries. J Biomed Opt (2006) 0.82
Fluorescence-enhanced three-dimensional lifetime imaging: a phantom study. Phys Med Biol (2007) 0.82
Reconstruction of sectional images in frequency-domain based photoacoustic imaging. Opt Express (2011) 0.81
Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging. Nanomedicine (Lond) (2014) 0.81
Investigation of structure factors in dense colloidal suspensions using frequency domain photon migration: polydisperse systems. J Colloid Interface Sci (2004) 0.79
Quantifying multimodal contrast agent biological activity using near-infrared flow cytometry. Contrast Media Mol Imaging (2012) 0.79
Investigational lymphatic imaging at the bedside in a pediatric postoperative chylothorax patient. Pediatr Cardiol (2014) 0.79
Determination of optical properties in semi-infinite turbid media using imaging measurements of frequency-domain photon migration obtained with an intensified charge-coupled device. J Biomed Opt (2004) 0.79
Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors. Anal Biochem (2013) 0.79
Development of a near-infrared fluorescence ELISA method using tyramide signal amplification. Anal Biochem (2012) 0.78
Alkaline phosphatase assay using a near-infrared fluorescent substrate merocyanine 700 phosphate. Talanta (2011) 0.77
Fast intersections on nested tetrahedrons (FINT): An algorithm for adaptive finite element based distributed parameter estimation. J Comput Phys (2008) 0.77